Cargando…

Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study

BACKGROUND: There have been no studies of the effect of non-alcoholic fatty liver disease (NAFLD) on cardiovascular events (CVEs) in patients with pre-diabetes (pre-DM), and diabetes mellitus (DM). We performed a community-based cohort study to evaluate the relationship between NAFLD and CVEs in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Qi-Rui, Liu, Shuo-Lin, Bi, Ya-Guang, Chen, Shuo-Hua, Wu, Shou-Ling, Cai, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086774/ https://www.ncbi.nlm.nih.gov/pubmed/35557545 http://dx.doi.org/10.3389/fcvm.2022.889597

Ejemplares similares

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
por: Qin, Li, et al.
Publicado: (2023)

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
por: Hu, Xiaomin, et al.
Publicado: (2022)

Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis
por: Wang, Meng, et al.
Publicado: (2022)

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
por: Hoebinger, Constanze, et al.
Publicado: (2022)

Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients
por: Wang, Zhe, et al.
Publicado: (2022)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study
por: Li, Xinghui, et al.
Publicado: (2023)

Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets
por: Liu, Jie, et al.
Publicado: (2022)

Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension
por: Catena, Cristiana, et al.
Publicado: (2022)

Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community–Based Cohort Study
por: Song, Qi–Rui, et al.
Publicado: (2022)

Arterial Stiffness, Biomarkers of Liver Fat, and the Development of Metabolic Dysfunction in Metabolically Healthy Population: A Prospective Study
por: Lin, Lin, et al.
Publicado: (2022)

Assessing cardiovascular remodelling in fetuses and infants conceived by assisted reproductive technologies: a prospective observational cohort study protocol
por: Bi, Wen-jing, et al.
Publicado: (2019)

Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study
por: Pang, Shuo, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study
por: Choi, JungMin, et al.
Publicado: (2022)

Corrigendum: Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study
por: Pang, Shuo, et al.
Publicado: (2022)

The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study
por: Dai, Wen, et al.
Publicado: (2021)

Systemic lupus erythematosus and the risk of cardiovascular diseases: A two-sample Mendelian randomization study
por: Huang, Shuo, et al.
Publicado: (2022)

A High Triglyceride-Glucose Index Value Is Associated With an Increased Risk of Carotid Plaque Burden in Subjects With Prediabetes and New-Onset Type 2 Diabetes: A Real-World Study
por: Jiang, Zhen-zhen, et al.
Publicado: (2022)

Research trends in cardiovascular tissue engineering from 1992 to 2022: a bibliometric analysis
por: Lai, Ping, et al.
Publicado: (2023)

Resveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseases
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2015)

Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning
por: Wang, Cheng, et al.
Publicado: (2022)

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort
por: Zou, Yao-Wei, et al.
Publicado: (2022)

Association of Neighborhood Alcohol Environment With Alcohol Intake and Cardiovascular Risk Factors in India: Cross-Sectional Evidence From APCAPS
por: Li, Yingjun, et al.
Publicado: (2022)

Cardiorespiratory Fitness and Endothelial Function in Aging Healthy Subjects and Patients With Cardiovascular Disease
por: Königstein, Karsten, et al.
Publicado: (2022)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
por: Lu, Yingdong, et al.
Publicado: (2022)

Gender-Based Association of Coronary Artery Calcification and Framingham Risk Score With Non-alcoholic Fatty Liver Disease and Abdominal Obesity in Taiwanese Adults, a Cross-Sectional Study
por: Tsou, Meng-Ting, et al.
Publicado: (2022)

The Non-linear Relationship Between Normal Range Systolic Blood Pressure and Cardiovascular or All-Cause Mortality Among Elderly Population
por: Sun, Shuo, et al.
Publicado: (2021)

Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes
por: Kamolvisit, Sarunporn, et al.
Publicado: (2021)

Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing
por: Xiao, Wenkai, et al.
Publicado: (2017)

Relationship between lifestyle and metabolic factors and carotid atherosclerosis: A survey of 47,063 fatty and non-fatty liver patients in China
por: Zhang, Chun, et al.
Publicado: (2022)

Liver biomarkers, genetic and lifestyle risk factors in relation to risk of cardiovascular disease in Chinese
por: Wang, Xinyu, et al.
Publicado: (2022)

Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects
por: Cao, Genmao, et al.
Publicado: (2021)

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus
por: Berezin, Alexander E., et al.
Publicado: (2020)

Prevalence, Clinical Features, and In-hospital Outcome of Fatty Liver Disease in Acute Aortic Dissection: A Single-Center Retrospective Study
por: Zuo, Yifan, et al.
Publicado: (2021)

Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies
por: Martins, Aline M. A., et al.
Publicado: (2021)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jhgsrifo209q4n8d3cp6a0khtu